
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
Author(s) -
Kathryn S. Hensley,
Marlou J. Jongkees,
Daryl Geers,
Corine GeurtsvanKessel,
Yvonne M. Mueller,
Virgil A. S. H. Dalm,
Grigorios Papageorgiou,
Hanka Steggink,
Alicja Górska,
Susanne Bogers,
Jan G. den Hollander,
Wouter F W Bierman,
L. B. S. Gelinck,
Emile F. Schippers,
Heidi S. M. Ammerlaan,
Marc van der Valk,
Marit G. A. van Vonderen,
Corine E Delsing,
Elisabeth H. Gisolf,
Anke H W Bruns,
Fanny N. Lauw,
Marvin A.H. Berrevoets,
Kim C.E. Sigaloff,
Robert Soetekouw,
Judith Branger,
Quirijn de Mast,
A.J.J. Lammers,
Selwyn H. Lowe,
Rory D de Vries,
Peter D. Katsikis,
Bart Rijnders,
Kees Brinkman,
Anna H E Roukens,
Casper Rokx
Publication year - 2022
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1003979
Subject(s) - reactogenicity , medicine , immunogenicity , vaccination , cohort , clinical endpoint , prospective cohort study , immunology , clinical trial , antibody